Prognostic factors for relapse in stage I seminoma: a new nomogram derived from three consecutive, risk-adapted studies from the Spanish Germ Cell Cancer Group (SGCCG).

MLA

Aparicio, J., et al. “Prognostic Factors for Relapse in Stage I Seminoma: A New Nomogram Derived from Three Consecutive, Risk-Adapted Studies from the Spanish Germ Cell Cancer Group (SGCCG).” Annals of Oncology, vol. 25, no. 11, Nov. 2014, pp. 2173–78. EBSCOhost, https://doi.org/10.1093/annonc/mdu437.

APA

Aparicio, J., Maroto, P., García del Muro, X., Sánchez-Muñoz, A., Gumà, J., Margelí, M., Sáenz, A., Sagastibelza, N., Castellano, D., Arranz, J. A., Hervás, D., Bastús, R., Fernández-Aramburo, A., Sastre, J., Terrasa, J., López-Brea, M., Dorca, J., Almenar, D., Carles, J., & Hernández, A. (2014). Prognostic factors for relapse in stage I seminoma: a new nomogram derived from three consecutive, risk-adapted studies from the Spanish Germ Cell Cancer Group (SGCCG). Annals of Oncology, 25(11), 2173–2178. https://doi.org/10.1093/annonc/mdu437

Chicago

Aparicio, J., P. Maroto, X. García del Muro, A. Sánchez-Muñoz, J. Gumà, M. Margelí, A. Sáenz, et al. 2014. “Prognostic Factors for Relapse in Stage I Seminoma: A New Nomogram Derived from Three Consecutive, Risk-Adapted Studies from the Spanish Germ Cell Cancer Group (SGCCG).” Annals of Oncology 25 (11): 2173–78. doi:10.1093/annonc/mdu437.